|
Mammograms usually detect the earliest signs of breast cancer before it can be felt by a woman or her health care provider. Mammography is considered the most effective method for breast cancer detection, but the technique is not perfect. Scientific studies show that early detection rates improve – by approximately 23% – with the use of CAD technology. Mammography CAD analysis serves as a second reader of mammograms and aids interpreting radiologists in the detection of mammographic abnormalities that may represent breast cancer. + Increase interpretation confidence and establish uniformity in your practice; + Increase early stage breast cancer detection rates and potentially reduce litigation exposure; + Generate additional revenue for the facility and interpreting radiologist; + Promote your competitive position and marketing opportunity; + Enhance peace-of-mind for the women you serve.
PlusCAD utilizes ImageChecker® Systems manufactured by R2 Technology/Hologic, Inc., the first mammography CAD system approved by the U.S. Food and Drug Administration. Based on clinical studies, researchers estimate that for every 100,000 breast cancers currently detected with screening mammograms, CAD technology could detect an additional 20,500 breast cancers. _____________________________________________ To contact us:
PlusCAD, Inc. 930 William Pitt Way U-PARC, Building A4, Suite #118 Pittsburgh, PA 15238
Phone: 1-888-665-8580 Fax: 412-826-3005 E-mail: info@pluscad.net Website: www.pluscad.com |
|
Links to R2 Technology Clinical Studies |
